Skip to main content

Addiction clinical trials at UCSF
1 in progress, 0 open to new patients

  • Dopaminergic Modulation of Frontostriatal Function With a Dopamine Agonist and COMT Inhibitor

    Sorry, in progress, not accepting new patients

    In this study, the investigators are looking at how people make decisions about reward-related items, both monetary and food related after taking either the dopamine agonist bromocriptine or the COMT inhibitor tolcapone, in healthy control subjects. Subjects will fill self-report questionnaires and undergo an MRI scan.

    San Francisco, California and other locations